CR8, (S)-Isomer (CAS 1084893-56-0)

CR8, specifically the (S)-isomer, is a selective and potent inhibitor of cyclin-dependent kinases (CDKs), key enzymes involved in regulating the cell cycle, transcription, and neuronal functions. CR8 inhibits several CDKs, particularly CDK1, CDK2, CDK5, and CDK9, by competing with ATP for binding to the ATP-binding pocket of these kinases, thus blocking their catalytic activity. This inhibition broadly impacts cellular processes, especially in terms of cell cycle control. By blocking CDK1 and CDK2, CR8 can induce cell cycle arrest, making it an excellent tool for studies focused on cell cycle dynamics and its regulatory mechanisms. Additionally, the inhibition of CDK5, which plays crucial roles in neuronal functions, allows researchers to explore its involvement in neural development and synaptic function. In research settings, CR8 is employed to examine the effects of CDK inhibition in various cellular contexts. It is particularly useful for understanding how cellular proliferation and growth can be modulated at a molecular level. Also, by affecting CDK5, CR8 has been used in investigations related to neuron function, aiding in the exploration of molecular pathways that underpin neural activity and connectivity. This contributes to broader insights into the complex mechanisms regulating cellular and neuronal behavior.